drugset / Trial / NCT02296814

Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis

NCT02296814 ↗

Phase 4 Completed 314 enrolled Hevert-Arzneimittel GmbH & Co. KG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study to verify the efficacy and tolerability of Sinusitis Hevert SL tablets compared to placebo in adult patients with acute, uncomplicated rhinosinusitis (inflammation of the nasal and paranasal sinuses).

Timeline

Start
2014-11
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sinusitis Hevert SL Unknown 2 unknown —

Indications